Literature DB >> 25133423

Inflammatory lymphangiogenesis in postpartum breast tissue remodeling.

Melody A Swartz.   

Abstract

Like many cancers, mammary carcinomas use lymphatic vessels to disseminate, and numerous clinical and experimental studies have documented a strong correlation between peritumoral lymphangiogenesis and tumor dissemination. At the same time, many other factors can affect the incidence, invasiveness, and mortality of breast cancer, including lactation history. Although lactation reduces overall cancer risk, patients diagnosed within 5 years of pregnancy have an increased incidence of metastatic disease. In this issue of the JCI, Lyons and colleagues demonstrate that postpartum breast tissue remodeling during involution coincides with inflammatory lymphangiogenesis. In mouse models, cyclooxygenase-2 (COX-2) inhibition during involution reduced the risk of cancer metastasis and correlated with decreased lymphangiogenesis. In addition to lymphangiogenesis, COX-2 inhibition reduces many of the immune-suppressive features of the tumor microenvironment, including development of myeloid-derived suppressor cells and regulatory T cells; therefore, these results support the notion that inhibiting COX-2 during lactation weaning may lessen the incidence of breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25133423      PMCID: PMC4151213          DOI: 10.1172/JCI77765

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.

Authors:  Xiping Xin; Mousumi Majumder; Gannareddy V Girish; Vik Mohindra; Takayuki Maruyama; Peeyush K Lala
Journal:  Lab Invest       Date:  2012-05-28       Impact factor: 5.662

2.  Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells.

Authors:  Sachiko Hirosue; Efthymia Vokali; Vidya R Raghavan; Marcela Rincon-Restrepo; Amanda W Lund; Patricia Corthésy-Henrioud; Francesca Capotosti; Cornelia Halin Winter; Stéphanie Hugues; Melody A Swartz
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

3.  Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis.

Authors:  Yasuyoshi Miyata; Kojiro Ohba; Tomohiro Matsuo; Shin-Ichi Watanabe; Tomayoshi Hayashi; Hideki Sakai; Hiroshi Kanetake
Journal:  Urology       Date:  2012-11-11       Impact factor: 2.649

4.  Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer.

Authors:  Traci R Lyons; Virginia F Borges; Courtney B Betts; Qiuchen Guo; Puja Kapoor; Holly A Martinson; Sonali Jindal; Pepper Schedin
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

5.  Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.

Authors:  Bronislaw Pytowski; Jeremy Goldman; Kris Persaud; Yan Wu; Larry Witte; Daniel J Hicklin; Mihaela Skobe; Kendrick C Boardman; Melody A Swartz
Journal:  J Natl Cancer Inst       Date:  2005-01-05       Impact factor: 13.506

6.  VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.

Authors:  Amanda W Lund; Fernanda V Duraes; Sachiko Hirosue; Vidya R Raghavan; Chiara Nembrini; Susan N Thomas; Amine Issa; Stéphanie Hugues; Melody A Swartz
Journal:  Cell Rep       Date:  2012-02-23       Impact factor: 9.423

7.  Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.

Authors:  Jen-Liang Su; Jin-Yuan Shih; Men-Luh Yen; Yung-Ming Jeng; Cheng-Chi Chang; Chang-Yao Hsieh; Lin-Hung Wei; Pan-Chyr Yang; Min-Liang Kuo
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

Review 8.  Lymphangiogenic factors, mechanisms, and applications.

Authors:  Wei Zheng; Aleksanteri Aspelund; Kari Alitalo
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 9.  Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop.

Authors:  Jessica M Faupel-Badger; Kathleen F Arcaro; Jane J Balkam; A Heather Eliassen; Foteini Hassiotou; Carlito B Lebrilla; Karin B Michels; Julie R Palmer; Pepper Schedin; Alison M Stuebe; Christine J Watson; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2012-12-21       Impact factor: 13.506

Review 10.  The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.

Authors:  Tara Karnezis; Ramin Shayan; Stephen Fox; Marc G Achen; Steven A Stacker
Journal:  Oncotarget       Date:  2012-08-19
View more
  3 in total

Review 1.  Macphatics and PoEMs in Postpartum Mammary Development and Tumor Progression.

Authors:  Alan M Elder; Alexander R Stoller; Sarah A Black; Traci R Lyons
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-06-13       Impact factor: 2.673

Review 2.  Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer.

Authors:  Virginia F Borges; Alan M Elder; Traci R Lyons
Journal:  Front Oncol       Date:  2016-11-02       Impact factor: 6.244

3.  Lymphatic endothelial cells prime naïve CD8+ T cells into memory cells under steady-state conditions.

Authors:  Efthymia Vokali; Shann S Yu; Sachiko Hirosue; Marcela Rinçon-Restrepo; Fernanda V Duraes; Stefanie Scherer; Patricia Corthésy-Henrioud; Witold W Kilarski; Anna Mondino; Dietmar Zehn; Stéphanie Hugues; Melody A Swartz
Journal:  Nat Commun       Date:  2020-01-27       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.